Oppenheimer & Co Inc’s Gilead Sciences Inc Position
Does Oppenheimer & Co Inc own Gilead Sciences Inc (GILD)? Yes — 283.0K shares worth $39M (+0.48% of its 13F portfolio) as of Q1 2026, up from 268.1K shares the prior filed quarter.
Position Value
$39M
Q1 2026
Shares
283.0K
% of Portfolio
+0.48%
Quarters Held
30
currently held
Position History GILD
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 283.0K | $39M | +0.48% |
| Q4 2025 | 268.1K | $33M | +0.47% |
| Q3 2025 | 293.3K | $33M | +0.40% |
| Q2 2025 | 297.5K | $33M | +0.44% |
| Q1 2025 | 290.2K | $33M | +0.49% |
| Q4 2024 | 286.3K | $26M | +0.39% |
| Q3 2024 | 284.5K | $24M | +0.36% |
| Q2 2024 | 288.5K | $20M | +0.31% |
| Q1 2024 | 295.7K | $22M | +0.36% |
| Q4 2023 | 299.0K | $24M | +0.45% |
| Q3 2023 | 332.4K | $25M | +0.51% |
| Q2 2023 | 340.6K | $26M | +0.53% |
| Q1 2023 | 348.6K | $29M | +0.61% |
| Q4 2022 | 351.3K | $30M | +0.69% |
| Q3 2022 | 417.8K | $26M | +0.60% |
| Q2 2022 | 393.4K | $24M | +0.52% |
| Q1 2022 | 398.8K | $24M | +0.43% |
| Q4 2021 | 429.7K | $31M | +0.55% |
| Q3 2021 | 452.2K | $32M | +0.59% |
| Q2 2021 | 417.4K | $29M | +0.52% |
| Q1 2021 | 350.8K | $23M | +0.45% |
| Q4 2020 | 339.3K | $20M | +0.42% |
| Q3 2020 | 390.3K | $25M | +0.62% |
| Q2 2020 | 397.9K | $31M | +0.79% |
| Q1 2020 | 431.7K | $32M | +0.98% |
| Q4 2019 | 380.1K | $25M | +0.61% |
| Q3 2019 | 385.6K | $24M | +0.67% |
| Q2 2019 | 395.0K | $27M | +0.73% |
| Q1 2019 | 396.3K | $26M | +0.69% |
| Q4 2018 | 411.8K | $26M | +0.81% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Oppenheimer & Co Inc’s full portfolio or all institutional holders of GILD.